A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients (MuGard)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01283906
Recruitment Status : Completed
First Posted : January 26, 2011
Last Update Posted : September 12, 2013
Information provided by (Responsible Party):
Access Pharmaceuticals, Inc.